A carregar...
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients
OBJECTIVE: The efficacy of tocilizumab (TCZ) in GCA is supported by two randomized controlled studies, in which TCZ allowed remission to be achieved after 52 weeks of treatment. However, after discontinuation of treatment, half of the patients relapsed. The aim of this study was to analyse the effic...
Na minha lista:
| Publicado no: | Rheumatol Adv Pract |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359771/ https://ncbi.nlm.nih.gov/pubmed/32685912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rap/rkaa017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|